个人简介
朱勇,研究员,博士生导师,2019年,作为特聘教授入职重庆医科大学。主要研究方向pre-mRNA转录后加工在细胞命运决定中的分子机制。先后以一作或通讯(含共同)在Nucleic Acids Res (2026,2014,2013)、Clin. Transl. Med (2025)、JMCB (2024)、Adv. Funct. Mater (2024)、Genes &Diseases (2023)、Molecular Cell (2018)等杂志发表多篇SCI论文。主持国家自然科学基金面上项目一项、重庆市创新创业重点项目一项,参与多个区域联合项目,累计科研经费300万元。获得教育部自然科学二等奖一项(参与)。
教育背景及工作经历
2002-2007第三军医大学医学学士学位检验医学
2008-2011重庆医科大学理学硕士学位生物化学与分子生物学
2011-2014北京协和医学院理学博士学位生物化学与分子生物学
2014-2019美国UC Irvine大学博士后访问学者
2019-2023重庆医科大学生命科学研究院特聘教授
2023至今重庆医科大学基础医学院研究员
学术兼职
2023-至今重庆市生物化学与分子生物学会副秘书长
奖项及荣誉
2018年,若干微小RNA和蛋白基因在髓系生成和白血病中的功能和机制研究,教育部自然科学二等奖(第7完成人)
主持科研项目
2021-2024年,国家自然科学基金面上项目,项目批准号:82070111
项目名称:选择性多聚腺苷酸化调控因子CFIm68介导的铁稳态平衡促进造血红系分化的功能和机制研究
代表性论文
1. S. Yu#, X. Zeng#, J. Chen#, Z. Lou, T. Jiang, Y. Ou, P. Du, J. Rao, X. Dai, M. Gong, J. Xu, P. Yi*, F. Wang*, X. Wang*,Y. Zhu*, Alternative polyadenylation links RNA processing to iron metabolism in human erythropoiesis. Nucleic Acids Research. 54 (2026)
2. X. Luo#, Q. Wei, L. Xie, N. Chen, B. Gu, J. Xu, X. Jiang, X. Zuo, H. Zhao, X. Liu, Y. Yang, T. Liu,Y. Zhu*, P. Yi*, J. Xu*, IGF2BP2 binding to CPSF6 facilitates m6A‐mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer. Clinical and Translational Medicine. 15 (2025)
3. B. Gu#, X. Zeng, M. Gong, X. Li, Q. Yu, Z. Tan, Z. Lou, T. Jiang, Y. Che, Y. Ao*,Y. Zhu*, Target Reprogramming the 3′UTR of Tumor‐Suppressor Genes by a siRNA Composite Nanoparticle for Glioblastoma Therapy. Advanced Functional Materials. 34 (2024)
4. J. Qiang#, S. Yu#, J. Li, Y. Rong, X. Wang*,Y. Zhu*, F. Wang*, Single-cell landscape of alternative polyadenylation in human lymphoid hematopoiesis. Journal of Molecular Cell Biology. 16 (2024)
5. X. Li#, Y. Che, X. Wang,Y. Zhu*, A pan-cancer analysis of the core pre-mRNA 3′end processing factors, and their association with prognosis, tumor microenvironment, and potential targets. Scientific Reports. 14 (2024)
6. D.-P. Wang#, F.-Y. Jiang#, X.-Y. Zeng#, Y.-J. Liu, R. Zhao, M.-Y. Wang, J. Luo, C. Chen*,Y. Zhu*, J.-M. Cao*, Crystal structure of RNA helicase from Saint Louis encephalitis virus and discovery of its inhibitors. Genes & Diseases, 389–392 (2023).
7.Y. Zhu#, X. Wang#, E. Forouzmand, J. Jeong, F. Qiao, GregoryA. Sowd, AlanN. Engelman, X. Xie, KlemensJ. Hertel, Y. Shi*, Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. Molecular Cell. 69, 62-74.e4 (2018).
8.Y. Zhu#, D. Wang, F#. Wang, T#. Li, L. Dong, H. Liu, Y. Ma, F. Jiang, H. Yin, W. Yan, M. Luo, Z. Tang, G. Zhang, Q. Wang, J. Zhang, J. Zhou, J. Yu, A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesis. Nucleic Acids Research, 4129–4143 (2013).